Kamboh, M. I. Et Al. 2006. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease. NEUROBIOLOGY OF AGING , vol.27, no.10 , 1435-1439.

Kamboh, M. I., Minster, R. L., Kenney, M., Ozturk, A., Desai, P. P., Kammerer, C. M., ... DeKosky, S. T.(2006). Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease. NEUROBIOLOGY OF AGING , vol.27, no.10, 1435-1439.

Kamboh, M. Et Al. "Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease," NEUROBIOLOGY OF AGING , vol.27, no.10, 1435-1439, 2006

Kamboh, M. I. Et Al. "Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease." NEUROBIOLOGY OF AGING , vol.27, no.10, pp.1435-1439, 2006

Kamboh, M. I. Et Al. (2006) . "Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease." NEUROBIOLOGY OF AGING , vol.27, no.10, pp.1435-1439.

@article{article, author={M. Ilyas Kamboh Et Al. }, title={Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease}, journal={NEUROBIOLOGY OF AGING}, year=2006, pages={1435-1439} }